Composite hyaluronate-type I collagen-fibrin scaffold in the therapy of osteochondral defects in miniature pigs by Filová, Eva et al.
 
 
PHYSIOLOGICAL RESEARCH ISSN 0862-8408






Physiol. Res. 56 (Suppl. 1): S5-S16, 2007 
 
 
Composite Hyaluronate-Type I Collagen-Fibrin Scaffold in the 
Therapy of Osteochondral Defects in Miniature Pigs 
 
E. FILOVÁ1, 2, M. RAMPICHOVÁ1, 2, M. HANDL3, A. LYTVYNETS4, R. 
HALOUZKA5, D. USVALD6, J. HLUČILOVÁ6, R. PROCHÁZKA6, M. 
DEZORTOVÁ7, E. ROLENCOVÁ7, E. KOŠŤÁKOVÁ8, T. TRČ3, E. ŠŤASTNÝ3, L. 
KOLÁČNÁ1, 2, M. HÁJEK7, J. MOTLÍK6, E. AMLER1, 2  
 
1Institute of Experimental Medicine of the Academy of Sciences of the Czech Republic, Prague, 
2Institute of Biophysics, Second Faculty of Medicine, Charles University, Prague, 3Orthopedic 
Clinic, University Hospital Motol, Prague, 4Institute of Physiology of the Academy of Sciences of 
the Czech Republic, Prague, 5Institute of Pathological Morphology, Faculty of Veterinary 
Medicine, University of Veterinary and Pharmaceutical Sciences, Brno, 6Institute of Animal 
Physiology and Genetics of the Academy of Sciences of the Czech Republic, Liběchov, 7MR-Unit, 
ZRIR, Institute for Clinical and Experimental Medicine, Prague, 8Technical University of Liberec, 
Faculty of Textile Engineering, Liberec, Czech Republic 
 
Received May 23, 2007 
Accepted May 29, 2007 





The potential of novel scaffold containing sodium hyaluronate, type I collagen, and fibrin was investigated in the 
regeneration of osteochondral defects in miniature pigs. Both autologous chondrocyte-seeded scaffolds and non-seeded 
scaffolds were implanted into two defects located in the non-weight-bearing zone of the femoral trochlea (defect A was 
located more distally and medially, defect B was located more proximally and laterally). Control defects were left 
untreated. Twelve weeks after the operation, the knees were evaluated in vivo using MRI. Six months after the 
implantation, the defects were analyzed using MRI, histological, and immunohistochemical analysis. In the A defects of 
chondrocyte-seeded scaffold group, hyaline cartilage and fibrocartilage was formed, containing type II collagen, acidic 
and neutral glycosaminoglycans while the non-seeded scaffold group was predominantly filled with fibrocartilage. 
Defects in the control group were predominantly filled with fibrous tissue. Histomorphometric analysis of 
photomicrographs revealed a significantly higher amount of hyaline cartilage in the cell-seeded scaffold group in A 
defects than in other groups. Both scaffold groups in A defects showed significantly less fibrous tissue than cell-seeded 
defects B and the control group. Both histological and MRI analysis proved that the novel composite scaffold has a 
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Isolated chondral or osteochondral defects, when 
left untreated, fail to heal. Moreover, large defects can 
progress to symptomatic degeneration of the joint. 
Therefore, the treatment of selected isolated defects may 
prevent or delay the development of osteoarthritis. 
Standard surgical techniques, such as debridement, 
drilling or microfracturing of subchondral bone, 
osteotomy, mosaicplasty, transplantation of autographs 
from non-weight bearing zone into former defect area, 
and soft tissue grafts, such as perichondrial, periosteal 
flap, joint capsule, or fascia have the potential to 
stimulate formation of new articular surface, and may 
decrease symptoms and improve the joint function 
(Niedermann et al. 1985, Hoikka et al. 1990, Buckwalter 
and Mankin 1998a). However, they are not able to restore 
normal articular cartilage (Buckwalter and Mankin 
1998a).  
One of the modern techniques involves 
autologous chondrocytes injected into the defect that is 
covered by periosteal flap sealed with fibrin glue 
(Brittberg et al. 1994, Breinan et al. 1997, 2001). 
However, in animal models, a positive effect of ACI was 
observed only three months after the implantation 
(Breinan et al. 2001), but no effect was observed after 12 
and 18 months (Breinan et al. 1997). That may be 
explained by the lack of retention of the cells in the defect 
due to possible displacement of the periosteal flap, and 
the location of the defect. 
The second generation of ACI technique (or 
ACT) involves autologous chondrocytes injected under a 
three-dimensional biodegradable scaffold such as 
collagen bilayer membrane (Chondro-GideTM membrane, 
Geistlich Biomaterials) (Marlovits et al. 2006).  
The third generation of ACT is based on 
autologous chondrocyte-seeded biomaterials as cell 
carriers (MACT). Hyaluronan derivative fleece, type- 
I/III collagen membrane, and polylactin and polyglactin 
are intensively examined in clinical studies (Pavesio et al. 
2003, Marlovits et al. 2005, Trattnig et al. 2005, 
Marlovits et al. 2006). In comparison with the second 
generation of ACT, this technique allows chondrocytes to 
redifferentiate and to produce their own extracellular 
matrix. Subjective and objective improvement has been 
observed in 76 % to 100 % of patients. In spite of these 
promising results, incomplete filling (Trattnig et al. 2005) 
and rare detachment of the scaffold have occurred 
(Marlovits et al. 2005).   
Hydrogels mimic the natural highly hydrated 
cartilage that contains above 90 % of water (Buckwalter 
and Mankin 1998b). They include naturally derived 
biopolymers, such as collagen, fibrin, chitosan, agarose, 
alginate, hyaluronic acid derivatives (Drury and Mooney 
2003, Ng et al. 2005), or synthetic polymers, such as 
polyvinyl alcohol, polyethylene oxide, and polyethylene 
glycol (Bryant and Anseth 2002, Kobayashi et al. 2003). 
Crosslinked hydrogels (Bryant and Anseth 2002), or 
porous scaffolds prepared from hydrogels by cross-
linking and/or by freeze-drying exhibit increased stiffness 
and reduced degradation velocity (Chang et al. 2003).  
They allow preparing scaffolds of variable composition, 
biological, and biomechanical properties, especially when 
they are combined with other hydrogels, woven or non-
woven scaffolds, and other polymer scaffolds (Minoura et 
al. 1998). In our previous study, we developed a novel 
composite scaffold consisting of sodium hyaluronate, 
type I collagen and fibrin, and proved its ability to 
regenerate osteochondral defects in rabbits within six 
weeks. The purpose of this study was to prove the long-
time efficacy of the same scaffold in cartilage 





The investigation was approved by the Expert 
Committee of the Institute of Physiology, Academy of 
Sciences, Prague, and conformed with the Czech Animal 
Protection Law № 246/92. Animals were premedicated 
with intramuscular 2.0 mg/kg azaperonum and 1 mg 
Atropin Biotika pro toto in the same syringe (posterior 
thigh – semitendinous and semimembranous muscles). 
Marginal auricular vein was used for anesthetic induction 
drugs (ketamine 20 mg/kg). Animals were intubated with 
2.5F tracheal tube without cuff. Anesthesia was 
maintained with 1.5 % isoflurane at 2 l/min constant 
flow. During in vivo MRI measurement the general 
anesthesia was done by continual infusion into marginal 
auricular vein with ketamine (20 mg/kg). 
 
Chondrocyte isolation and cell culture 
Small pieces of cartilage were taken from the 
left femoral trochlea of three miniature pigs (total of nine 
miniature pigs) under general anesthesia. After enzymic 
digestion, chondrocytes were collected and cultured for 
14 days in Iscove´s Modified Dulbecco´s Medium 
supplemented with 15 % fetal bovine serum (FBS), 3 g/l 
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NaHCO3, 100 IU/ml penicillin, 100 µg/ml streptomycin, 
4 mM L-glutamine, 20 µg/ml L-ascorbate-2-phosphate 
sesquimagnesium salt, 50 ng/ml insulin-like growth 
factor (IGF-I, human recombinant (hr), Sigma), 10 ng/ml 
basic fibroblast growth factor (bFGF, hr, Roche Applied 
Science), and 1 ng/ml transforming growth factor β2 
(TGF-β2 from porcine platelets, Sigma-Aldrich). During 
the subsequent 9 days the cells were cultured in the same 
medium but containing 10 % FBS. The cells were 
incubated at 37 °C in a humidified atmosphere with 5 % 
CO2. The culture was passaged always before confluence 




The scaffolds were prepared in the wells of a 24-
well plate at about 4 °C by mixing 33 µl of sodium 
hyaluronate (10 mg/ml, 1500 kDa, kindly provided by 
CPN, CR) with 49.4 µl of 1 mg/ml type I collagen in 0.1 
M acetic acid (Collagen type I from calf skin, acid 
soluble, Sigma) and neutralized with 1 M KOH. 66 µl of 
cell suspension (4.3 × 106 chondrocytes) or 66 µl of 
media, respectively, was then added. Into this medium 
containing five times higher concentrations of growth 
factors compared to culture medium and 20 % FBS, we 
added 0.16 ml of Tissucol solution in aprotinin 
(fibrinogen 70-110 mg/ml, aprotinin 3000 
kallidinogenase-inactivator units/ml), and 0.16 ml of 
thrombin solution (4 IU/ml) in CaCl2 (40 µmol/ml, 
Tissucol® Kit, Baxter). Two identical scaffolds were 
prepared for each animal. The gel was formed at 37 °C. 
Subsequently, the culture medium was added and the 
scaffold was placed in an incubator with a humidified 
atmosphere, 5 % CO2 at 37 °C for one day.  
 
MRI examination 
Twelve weeks after the implantation, in vivo 
MRI evaluation of the knees was performed under 
general anesthesia, euthanasia of miniature pigs was 
performed twenty-four weeks after the implantation by 
intravenous anesthetic thiopental overdosing, and the 
entire knees were evaluated using MRI. MRI examination 
was performed on a whole-body MR system Siemens 
Vision 1.5 T (Erlangen, Germany) using a standard CP 
head coil. Subjects were measured in a supine position 
with the knee in the middle of the head coil. MR images 
were obtained in sagittal orientation using T1-weighted 
spin echo (TR/TE = 500/12 ms) and FLASH (TR/TE = 
999/11 ms) sequence, FOV = 280 mm, slice thickness 3 
mm. The same T1-weighted sequence was repeatedly 
applied after contrast agent (Gd-DTPA) application. 
 
Histological examination and immunohistochemistry 
Femoral trochleas were taken away and fixed in 
10 % phosphate-buffered formalin for 48 h for 
histological and immunohistochemical analysis. Briefly, 
after 48-h fixation, the samples were washed in water and 
decalcified in 8 M formic acid for seven days. After 
decalcification, the samples were put into a 5 % sodium 
sulfate solution for 8 h and subsequently washed using 
tap water for 24 h. The samples were embedded in 
paraffin and 4 µm thick sections were stained with 
hematoxylin-eosin. Staining with Alcian blue at pH 2.5 
and the PAS reaction was done to verify acidic and 
neutral GAG synthesis. The preparations were dehydrated 
and embedded in Canadian balsam. 
Immunohistochemical staining was done to identify type 
II collagen using a monoclonal antibody against type II 
collagen, clone II-II6B3, obtained from Developmental 
Studies Hybridoma Bank, University of Iowa, Iowa City. 
Subsequently, the biotinylated secondary antibody and 
streptavidin-peroxidase (both Immunotech) were used. 
Reactions were visualized using the DAB Chromogen Kit 
(Immunotech). The slides were counterstained with 
hematoxylin.   
 
Histological and histochemical scoring system  
The repair of osteochondral defects in all groups 
was compared by the scoring system for histological and 
histochemical results with maximum 24 points, modified 
from van Susante et al. (1999). The blinded analysis was 
performed by two authors.  
 
Histomorphometric analysis 
Histomorphometric analysis of photomicro-
graphs of the histological preparations was performed 
using several randomly selected areas of each defect 
(Microscope IX 51, Olympus). The amount of hyaline 
cartilage, fibrocartilage, and fibrous and/or fibrovascular 
tissue was measured as their percentage of the total area 
of defect. Total area of the defect was measured by 
marking the borders of the defect to the defect base and 
the adjacent cartilage. The blinded analysis was 
performed by two authors using software Ellipse 
(ViDiTo, Kosice, Slovakia). The evaluation of hyaline 
cartilage, fibrocartilage and fibrous tissue was performed 
according to Breinan 2001.  
 




Quantitative data of histomorphometric analysis 
were presented as mean ± SEM (standard error of the 
mean). Statistical analysis was performed using One Way 
Analysis of Variance (ANOVA) and Student-Newman-
Keuls Method. The level of significance was set at 0.05. 
Only groups with 3 animals were analyzed.  
Results 
 
Defect simulation and treatment  
Patella was dislocated on the lateral site after 
medial arthrotomy of the knee-joint. Menisci remained 
untouched. Two experimental circular lesions were 
created by a 6-mm (diameter) and 2-mm (depth) drill 
 
 
Fig. 1. Femoral trochlea of miniature pigs 24 weeks after the implantation. Defect A was located more distally and medially; defect B
was located more proximally and laterally. Arrows show the positions of defect B. (A and B – chondrocyte-seeded scaffold group; C, D –
non-seeded scaffold group; E, F – control group) 
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harvester approaching the subchondral bone in the non-
weight-bearing zone in the upper part of medial condyle. 
To follow the complex effect of cell implantation and 
knee loading for healing processes, two localizations of 
cartilage lesion were investigated in the present study. 
Defect A was located more distally and medially (closer 
to the weight-bearing zone); defect B was located more 
proximally and laterally, and farther from the non-
weight-bearing zone. 
The defects were filled with two pieces of 
scaffold (as sandwich) containing cultured autologous 
chondrocytes in three animals (chondrocyte-seeded 
scaffold group), with two pieces of scaffold without cells 
in three animals (non-seeded scaffold group). In the 
control group of three animals, defects A were created 
and left untreated. The scaffolds were glued to the 
adjacent tissue and subchondral bone with Tissucol® 
fibrin glue. Wound healing proceeded without any 
complication in all cases during the whole post-operation 
period. Miniature pigs were not limited in their 
movement after surgery.  
 
Macroscopic evaluation  
Chondrocyte-seeded scaffold group. The 
composite scaffold (hyaluronate/type I collagen/fibrin) 
seeded with autologous chondrocytes in miniature pigs 
resulted in almost completely filled defect A after six 
months. Tissue visually resembled hyaline cartilage (Figs 
1A and 1B). The surface was predominantly 
homogeneous; in one animal the medial edge was 
irregular and incompletely filled with repaired tissue. The 
contours of the defect were visible. Defects B were 
partially filled with the white tissue in distal part adjacent 
to hyaline cartilage. The proximal yellow part adjacent to 
fibrous tissue (fibrous capsule) was not filled with the 
tissue and resembled fibrous tissue (Figs 1A and 1B).  
Non-seeded scaffold group. Defects A were 
filled completely with white tissue, and one defect was 
filled only partially (Figs 1C and 1D). The color and 
surface were not homogeneous and the repaired tissue 
partially resembled the adjacent cartilage. Defects B were 
done in two animals. The defects were partially filled 
with white tissue; the proximal part of the defect was not 
filled and resembled fibrous tissue (Fig. 1D). 
Control group. The defect was filled in one case 
and weakly filled in two animals; the color was white-
yellowish with uneven surface and distinct contours (Figs 
1E and 1F). 
 
Histological and histochemical score 
Structural characteristics of the repaired tissue 
(Table 1) revealed a higher score in the A defects of 
chondrocyte-seeded scaffold group (total score – 26, 21, 
and 23) in comparison with chondrocyte-seeded scaffold 
in defects B (total score – 16, 9, and 9), and slightly 
higher than other groups (total score – 16, 19, and 21 of 
defects A; 19, and 19 of defects B) of non-seeded 
scaffold group; control group (total score – 13, 14, and 
20). Its improvement was observed in all tested 
parameters. Chondrocyte-seeded scaffold in defects B 
revealed a lower score than non-seeded scaffold in defect 
A (total score – 16, 18, and 21).  
 
Histomorphometric analysis 
Defects A of chondrocyte-seeded scaffold group 
contained significantly more hyaline cartilage than other 
groups. Non-seeded scaffold in defect A revealed 
significantly more fibrocartilage compared to 
chondrocyte-seeded scaffold in defects B. However, both 
defects B of chondrocyte-seeded scaffold group and 
control group had significantly more fibrous tissue than 
both types of scaffolds in defects A. (Table 2)   
 
Magnetic resonance images 
Three months after the implantation, defects A 
with chondrocyte-seeded scaffolds were well visible with 
minimal edema in all cases. Joint cartilages were slightly 
inhomogeneous without signs of synovitis. In the non-
seeded scaffold group, defects A were distinct with 
prominent edema in the adjacent bone; joint cartilage was 
inhomogeneous. After application of the contrast agent, 
the tissue saturation was moderate, and predominantly at 
the basis of the defects. Synovium was slightly thicker 
with signs of synovitis. Defects in the control group were 
clearly visible without high edema and rather 
inhomogeneous. The signal of the defects slightly 
enhanced after contrast agent application and the basis 
showed signs of synovitis. 
 Six months after the implantation, defects A 
implanted with chondrocyte-seeded scaffolds remained 
still visible, without signs of edema in the adjacent bone. 
The joint cartilage was slightly inhomogeneous. In the 
non-seeded scaffold group, defects A were clearly visible 
with sclerotic basis that could lead to slower regeneration. 
Edema decreased and the cartilage remained slightly 
inhomogeneous. In the controls, the cartilage has become 
homogeneous, the edema decreased. The defects were not 
unambiguously differentiated. 




Table 1. Histological and histochemical scoring system, modified from van Susante et al. (1999); (AC, BC – chondrocyte-seeded 
scaffolds implanted in defects A, and B, respectively; A, B – non-seeded scaffolds implanted in defects A, and B, respectively; control – 
defects without treatment) 
 
Characteristic  AC BC A B Control 
Nature of predominant tissue       
 Cellular morphology (I)       
   Hyaline articular cartilage (4) 2 0 0 0 0 
   Incompletely differentiated (2) 1 0 3 2 1 
   Fibrous tissue and bone (0) 0 3 0 0 2 
 Alcian blue staining of the matrix (II)       
   Normal or near normal (3) 2 0 1 0 0 
   Moderate (2) 1 0 2 2 1 
   Slight (1) 0 3 0 0 2 
   None (0) 0 0 0 0 0 
Structural characteristics       
 Surface regularity (III)       
   Smooth and intact (3) 3 0 1 2 0 
   Superficial horizontal lamination (2) 0 2 2 0 3 
   Fissures, 25-100% of the thickness (1) 0 0 0 0 0 
   Severe disruption or fibrillation (0) 0 1 0 0 0 
 Structural integrity (IV)       
   Normal                                              (2) 1 0 0 0 0 
   Slight disruption, including cysts (1) 2 2 3 2 3 
   Severe disintegration (0) 0 1 0 0 0 
 Thickness (V)       
   100% of normal adjacent cartilage (2) 2 0 1 0 0 
   50-100% of normal cartilage (1) 1 3 2 2 3 
   0-50% of normal cartilage (0) 0 0 0 0 0 
 Bonding to the adjacent tissue (VI)       
   Bonded at both sides and subchondral bone (2) 3 2 3 2 3 
   Bonded partially (1) 0 1 0 0 0 
   Not bonded (0) 0 0 0 0 0 
Freedom from cellular changes of degeneration       
 Hypocellularity (VII)       
   None (3) 3 1 2 2 1 
   Slight (2) 0 1 1 0 0 
   Moderate (1) 0 1 0 0 2 
   Severe (0) 0 0 0 0 0 
 Chondrocyte clustering (VIII)       
   None (2) 2 1 1 0 2 
   <25% of cells (1) 1 1 2 2 1 
   25-100% of cells (0) 0 1 0 0 0 
Freedom from degenerative changes in adjacent cartilage (IX)       
 Normal cellularity, no clusters, normal staining (3) 2 0 0 0 1 
 Normal cellularity, mild clusters, moderate staining (2) 1 3 2 2 2 
 Mild or moderate hypocellularity, slight staining (1) 0 0 1 0 0 
 Severe hypocellularity, poor or no staining (0) 0 0 0 0 0 
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Histological examination and immunohistochemistry 
Chondrocyte-seeded scaffold group. Defects A 
were twice thicker than normal cartilage, approaching the 
subchondral bone (Fig. 2A). Repaired cartilaginous tissue 
filled the defects; the repaired tissue was slightly 
disintegrated. The collagen fibers were horizontally 
oriented on the surface and vertically in the deep part of 
the defects. All tissues revealed more intense staining of 
acidic GAGs than neutral GAGs (Figs 2C and 2E). The 
new repaired tissue was well integrated to both adjacent 
cartilage and bone. Type II collagen was present in all 
samples; intense staining was found both in the middle 
and the deep part of the defects (Fig. 2G). Defects B, 
however, were filled with fibrovascular and lipid tissue 
with synovium at the surface (Fig. 2B). Tissue formation 
was irregular, and PAS-positive substances were present 
in subchondral bone (Fig. 2D and 2F). In one defect, 
inflammatory cells were present in the repaired tissue. 
Type II collagen staining was negative in the repaired 
tissue (Fig. 2H). 
Non-seeded scaffold group. Defects A were flat 
and filled with mature fibrocartilage or cartilage (Fig. 
3A), in one sample with superficial inflammatory 
infiltration. Alcian-blue- positive substances were 
observed in the surface area (Figs 3C and 3E); type II 
collagen staining with moderate intensity was 
predominantly present in the central part of the defect and 
in tissue adjacent to the subchondral bone (Fig. 3G). The 
repaired tissue was well integrated to adjacent bone and 
cartilage. Some fissures were present in one defect. 
Defects B were filled with flat fibrocartilaginous tissue 
that was horizontally structured with good binding to 
adjacent tissues (Fig. 3B). Acidic GAGs were present in 
the upper part of the defect. The intense or moderate PAS 
positive staining (Fig. 3D and 3F) was observed together 
with moderate type II collagen staining (Fig. 3H); they 
were concentrated in the deeper regions of the repaired 
tissue. 
Control group. Two defects were partially filled 
with chaotic sparse fibrous tissue that revealed both GAG 
and type II collagen staining negative (Figs 4A and 4B 
and 4C). The third defect was filled with 
fibrocartilaginous tissue where some fissures were 
observed. Moreover, moderate Alcian blue and type II 
collagen staining were observed in the subchondral bone 





Chondral defects are reported not to regenerate 
but to be filled by fibrous tissue (Shortkroff et al. 1996). 
In addition, also treatment of chondral defects with 
chondroitinase ABC, and fibrin glue containing growth 
factors resulted in development of fibrous tissue 
(Hunziker and Rosenberg 1996). On the other hand, 
osteochondral defects are able to regenerate without 
treatment by producing a higher amount of 
proteoglycans, type I and II collagen within six to eight 
weeks. Later, a decreasing amount of proteoglycans and 
higher amount of collagen was observed till six months 
after the operation (Furukawa et al. 1980).  
Scaffolds seeded with chondrocytes and cultured 
in vitro support the production of extracellular matrix by 
chondrocytes, mainly GAGs, and type II collagen 
(Pavesio et al. 2003, Trattnig et al. 2005). Our aim was to 
prepare a scaffold supporting cell proliferation, 
differentiation, and thus regeneration of the defects.  
Heterologous chondrocyte-seeded fibrin 
implanted into the osteochondral defect in the weight-
bearing zone was so far reported to repair the defect to a 
very limited extent. From three weeks after the 
implantation, many dead cells were observed in the 
central part of the defects. This was accompanied by 
Table 2. Histomorphometric analysis of photomicrographs of the defects. Content of hyaline cartilage, fibrocartilage, and fibrous and/or 
fibrovascular tissue in the defect was determined as a percentage of the total defect area (mean ± S.E.M.). (AC, BC – chondrocyte-
seeded scaffolds implanted in the defects A, and B, respectively, A, and B – non-seeded scaffolds implanted in defect A, and B, 
respectively, control – defects without treatment) 
 
 AC (%) BC (%) A (%) B (%) Control (%) 
Hyaline cartilage 48.72 ± 17.27 0 16.68 ± 8.92 30.80 ± 6.03 0 
Fibrocartilage 32.65 ± 6.14 19.23 ± 10.39 66.89 ± 7.41 49.70 ± 13.46 31.23 ± 11.94 
Fibrous/ fibrovascular 
tissue 
18.63 ± 11.2 80.77 ± 10.39 16.43 ± 14.35 19.50 ± 19.50 68.77 ± 11.94 
 
 





Fig. 2. Histology of osteochondral defects A (A, C, E, G), and defects B (B, D, F, H) of the chondrocyte-seeded scaffold group after 24 
weeks using HE staining (A, B), Alcian blue staining and PAS reaction at pH 2.5 (C, D, E, F), and immunohistochemical staining using 
monoclonal antibody against type II collagen (G, H). Magnification × 200 (A), × 100 (B, E, F, H), × 40 (D, G).  
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Fig. 3. Histology of osteochondral defects A (A, C, E, G), and B (B, D, F, H) of the non-seeded scaffold group after 24 weeks using HE 
staining (A, B), Alcian blue staining and PAS reaction at pH 2.5 (C, D, E, F), and immunohistochemical staining using monoclonal 
antibody against type II collagen (G, H). Magnification × 100 (A, C, E, F), × 40 (B, D, G, H).  





Fig. 4. Histology of osteochondral defects of the control group after 24 weeks using HE staining (A), Alcian blue staining and PAS 
reaction at pH 2.5 (B, D), and immunohistochemical staining using monoclonal antibody against type II collagen (C) which showed 
chaotic sparse fibrous tissue with negative both GAG and type II collagen staining (A, B, C). Magnification × 40 (A, C, D), × 100 (B).  
 
 
inflammatory cell migration into progressively degraded 
fibrin, and subsequently, fibrocartilage formation (van 
Susante et al. 1999). To improve the biomechanical and 
biological properties of fibrin, we developed a composite 
scaffold containing type I collagen, hyaluronic acid, and 
fibrin. The regenerative potential of the scaffold was 
already proved in a six-week study in rabbits (data not 
published yet) where hyaline cartilage was predominantly 
formed in osteochondral defects. This long-term study 
proved the healing potential of the method, but also a 
positive effect of joint loading on regeneration process. 
Defects A (in the middle of condylus medialis) were 
located more closely to the weight-bearing zone of the 
joint. They were subjected to higher passive loading 
compared to the defects located in the proximal part of 
femoral trochlea (defects B), while the defects B were 
primarily subjected to shear stress. In the cell-seeded 
scaffolds in defects A, regenerated tissue was 
predominantly filled with hyaline and fibrocartilaginous 
tissue, while the non-seeded scaffolds formed 
predominantly fibrocartilage, and defects in the control 
group contained fibrous tissue. In the cell-seeded group, 
the hyaline tissue was present predominantly near the 
base of the lesion and at the borders; fibrocartilage was 
predominantly found in the central part of the defects, 
and fibrous tissue was located on the surface. The same 
distribution of tissue types was observed in ACI treated 
osteochondral defects three and six months after the 
implantation (Breinan et al. 2001). Our results are also in 
accordance with our previous six-week rabbit experiment 
where the defects were also situated in the non-weight-
bearing zone of femoral condyle. On the other hand, the 
repair of the proximal defects was diminished probably 
due to decreased hydrostatic pressure and increased shear 
stress. Some hypotheses maintain that shear stress and 
strain applied to cells result in fibrous tissue formation 
while compression of the cells by hydrostatic pressure 
results in hyaline cartilage formation (McMahon et al. 
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2004, Kelly and Prendergast 2005).  
Interestingly, bioreactor utilizing intermittent 
pressure and perfusion significantly stimulated both the 
collagen and GAG synthesis by chondrocytes (Carver and 
Heath 1999), In contrast, in a spinner flask, the shear 
stress applied to chondrocytes increased the synthesis of 
type I collagen, and the fibroblast-like phenotype of 
chondrocytes at the scaffold periphery (Vunjak-
Novakovic et al. 1999).  
In conclusion, the composite scaffold prepared 
from sodium hyaluronate, type I collagen and fibrin 
proved its ability to regenerate the osteochondral defect 
of miniature pigs in a six-month study. The best 
regeneration of hyaline cartilage and fibrocartilage was 
observed in the autologous chondrocyte-seeded scaffold 
group while the non-seeded scaffold group and control 
group revealed fibrocartilage and fibrous tissue 
formation, respectively. According to these results we 
suggest that the novel composite scaffold is promising for 
treatment of osteochondral defects.  
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